Subscribe: MedWorm: Arrhythmia
Added By: Feedage Forager Feedage Grade B rated
Language: English
arrhythmia  arrhythmias  cardiac  company  device  fda  health  heart  medical  medworm message  medworm  new  patients  source 
Rate this Feed
Rate this feedRate this feedRate this feedRate this feedRate this feed
Rate this feed 1 starRate this feed 2 starRate this feed 3 starRate this feed 4 starRate this feed 5 star

Comments (0)

Feed Details and Statistics Feed Statistics
Preview: MedWorm: Arrhythmia

MedWorm: Arrhythmia News provides a medical RSS filtering service. Thousands of medical RSS feeds are combined and output via different filters. This feed contains the latest news in Arrhythmia

Last Build Date: Thu, 15 Feb 2018 02:29:22 +0100


Is FDA Getting More Cozy with AI?

Wed, 14 Feb 2018 20:25:50 +0100

The use of artificial intelligence (AI) is undoubtedly on the rise in healthcare. From fledging medtech companies to established giants like Watson IBM—many firms are riding the current AI wave. Not only are companies embracing technology, but so is FDA. Recently the agency gave approval to San Francisco-based’s Contact application, a type of clinical decision support software designed to analyze CT results that could notify providers of a potential stroke in their patients. “What it’s doing is comparing the imaging features in that patient with the millions of images it has been trained on in the past, in order to identify a specific disease, which is a large vessel occlusion,” Chris Mansi MD, president and CEO of, told MD+DI. Once the Contact Application analyz...

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.

Sleep Apnea Might Put CABG Patients at Risk for Ventricular Arrhythmias Sleep Apnea Might Put CABG Patients at Risk for Ventricular Arrhythmias

Mon, 05 Feb 2018 20:52:48 +0100

Sleep-disordered breathing (SDB) is associated with abnormal cardiac repolarization before coronary artery bypass graft surgery (CABG), according to new research.Reuters Health Information (Source: Medscape Medical News Headlines)

Apple Wants a Bigger Bite of the Healthcare Fruit

Fri, 02 Feb 2018 19:55:21 +0100

Apple is trying to bear more fruit in healthcare with iOS healthcare applications on the iPhone and the iWatch. The company recently introduced a significant update to the Health app with the iOS 11.3 beta that allows customers to see their medical records on their iPhone. The updated Health Records section within the Health app is designed to bring together hospitals, clinics, and the existing Health app to allow users to see their medical data from multiple providers. At least 12 institutions have already agreed to make the feature available to their patients. Jordan Shlain, MD, founder of HealthLoop, will share his views on consumerizing healthcare during an opening plenary session Tuesday, February 6, 2018, at the MD&M West Conference and Expo. Use promo code "MDDI" for 20% off con...

Report: Apple in pursuit of FDA approval for iWatch-connected heart app

Fri, 02 Feb 2018 17:18:04 +0100

Apple (NSDQ:AAPL) is taking another major step into the healthcare market as it has begun to collect data it said could be used in pursuit of an FDA approval for an iOS based health application, according to a MobiHealthNews report. Participants in the study recently received prompts to sign informed consent documents that would allow the company to begin collecting data it says “will be used for FDA submission to seek approval of the investigational device,” according to MobiHealthNews. Apple isn’s seeking approval for a new device, though – it’s seeking a nod from the federal watchdog for the application underlying the heart study, and its included algorithms for detecting arrhythmias, according to the report. The study was originally announced last September in...

Breast cancer treatments could cause heart failure

Thu, 01 Feb 2018 21:06:13 +0100

A new scientific statement issued today by the American Heart Association reveals some breast cancer therapies can increase the risk of heart arrhythmia and disease. (Source: the Mail online | Health)

High blood pressure - these vitamin supplements will lower your risk of heart attacks

Wed, 31 Jan 2018 12:47:00 +0100

Vitamin D supplements could help to reverse damage to blood vessels after suffering from high blood pressure, scientists have revealed. Cardiovascular damage increases the risk of deadly cardiac arrhythmia. (Source: Daily Express - Health)

MedWorm Message: If you are looking to buy something in the January Sales please visit for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.

Philips joins $9m round for remote-care co LindaCare

Wed, 24 Jan 2018 17:03:30 +0100

Digital health company LindaCare has landed an $8.7 million Series B round, with investments made by Philips (NYSE:PHG), PMV, Capricorn ICT Arkiv, Connecticut Innovations and others. The Belgium-based company said it plans to use the newly-acquired funds to accelerate its U.S. market expansion and product commercialization, as well as build out its existing patient monitoring software platform for a broader range of cardiac diseases. “This investment is a significant step for us, as it enables LindaCare to execute faster on our ambitious vision and strategy, and to take a leading market position across both Europe and the US,” founder & CEO Shahram Sharif said in prepared remarks. “With Philips onboard as a strategic partner, alongside existing and new venture ca...

Cyclizine is sold in Denmark as an over-the-counter drug and has serious side effects when overdosed - Petersen K, Hjorth P.

Thu, 18 Jan 2018 16:42:31 +0100

Cyclizine is sold in Denmark as an over-the-counter drug and affects not only histaminergic but also muscarinergic, serotonergic and α-adrenergic receptors, with side effects such as respiratory depression and cardiac arrhythmias, leading to fatalities. D... (Source: SafetyLit)

An Error Message Worth Taking to Heart

Wed, 17 Jan 2018 21:37:55 +0100

In today's digital world we encounter alert messages on everything from our computers and mobile devices to our washing machines. It's not unusual to become desensitized to these messages and let them go ignored for too long. But a recent FDA safety communication serves as a reminder that some alerts warrant immediate attention, particularly when they involve a medical device that is supposed to keep you alive. The agency warned patients and caregivers that the Zoll LifeVest 4000, a wearable defibrillator used to treat life-threatening arrhythmias in adults and children at risk for sudden cardiac arrest, may fail to deliver treatment when needed if the device is not replaced soon after displaying a message instructing the user to call Zoll for service. Although the alert does inform the us...

The Startup Caf é, the Place where Healthcare IT Decision-Makers and New Companies can Meet

Tue, 16 Jan 2018 11:00:00 +0100

17 - 19 April 2018, Berlin, Germany. Whether they develop apps that detect the early stages of cardiac arrhythmia or cybersecurity software for hospitals, startups in the healthcare IT sector are flexible, highly innovative and can make a significant contribution to digitalising the healthcare system. (Source: eHealth News EU)

Examining the prospective relationship between pre-disaster respiratory sinus arrhythmia and post-disaster posttraumatic stress disorder symptoms in children - Mikolajewski AJ, Scheeringa MS.

Tue, 16 Jan 2018 04:45:18 +0100

Previous studies have examined the concurrent relationship between posttraumatic stress disorder (PTSD) and a range of psychophysiological variables, including respiratory sinus arrhythmia (RSA). However, there is a lack of research examining the prospecti... (Source: SafetyLit)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.

Mother-child coregulation of parasympathetic processes differs by child maltreatment severity and subtype - Lunkenheimer E, Busuito A, Brown KM, Skowron EA.

Tue, 16 Jan 2018 04:45:18 +0100

Parasympathetic processes appear to underlie maladaptive parent-child interactions in maltreating families, but it is unknown whether parent-child coregulation of respiratory sinus arrhythmia (RSA) differs by child maltreatment severity and subtype. RSA co... (Source: SafetyLit)

Abbott launches new ablation catheter in Europe

Fri, 12 Jan 2018 16:17:59 +0100

Abbott‘s (NYSE:ABT) sensor-enabled Advisor HD Grid mapping catheter has won CE Mark approval in the European Union. The device is designed for use in any chamber of the heart during cardiac ablation. Physicians use mapping catheters to identify areas of cardiac tissue that are responsible for sending erratic electrical signals that cause arrhythmias. Abbott touted its device as having a first-of-its-kind grid configuration of electrodes that improves data collection. Linear or circular mapping catheters sometimes experience signal disruptions when the orientation of the catheter changes, Abbott explained. But its Advisor HD Grid device is designed to avoid signal loss by collecting data horizontally and vertically along a grid that’s configured with 16 sensors. The catheter c...

Abbott Expands Portfolio of MRI-Ready Devices

Wed, 03 Jan 2018 19:20:18 +0100

FDA gave MR-conditional labeling to two of Abbott's cardiac rhythm management (CRM) devices, a move that further boosts the company's ability to compete with its peers in the space. The Abbott Park, IL-based firm said patients who receive a Quadra Assura MP cardiac resynchronization therapy defibrillator (CRT-D) or a Fortify Assura implantable cardioverter defibrillator (ICD) are now able to have an MRI in the future if need be. The Quadra Assura and the Fortify Assura are two of Abbott's most widely-used high voltage devices, the company noted. In September 2016, Abbott won FDA approval for MR-conditional labeling for the Ellipse ICD, which represented the first major step toward closing an important gap that previously existed in St. Jude's portfolio, prior to Abbott and St. Jude merging...

The 8th Annual Alexander Awards: The Best Tox Reading of 2017

Tue, 02 Jan 2018 21:17:32 +0100

Alexander Gettler Once again, last year’s outstanding examples of long-form journalism dealing with topics related to medical toxicology were dominated by coverage of the opioid crisis, its origins and the resulting carnage. The must-read article of the year was “The Family That Built a Empire of Pain,” Patrick Radden Keefe’s massive history of the Sacklers, one of America’s richest clans, much of whose wealth comes from their ownership of Purdue Pharma and the marketing and distribution of Oxycontin. The article, which appeared in the New Yorker, notes that the clan’s patriarch, Arthur Sackler, worked his way through medical school in the 1940s by serving as a copywriter for a New York ad agency that targeted targeted physicians and medical workers. He...

Frailty Syndrome: A Problem in the Management of Arrhythmias Frailty Syndrome: A Problem in the Management of Arrhythmias

Thu, 28 Dec 2017 05:14:34 +0100

How prevalent is frailty in everyday practice and how does it influence the clinical management of arrhythmias?Europace (Source: Medscape Today Headlines)

MedWorm Message: If you are looking to buy something in the January Sales please visit for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.

Survival Down With Ventricular Arrhythmia Early Post CF - LVAD

Tue, 26 Dec 2017 18:00:00 +0100

Findings from retrospective review of patients with contemporary continuous flow LVAD implantation (Source: Pulmonary Medicine News - Doctors Lounge)

Researchers are developing light therapy as a non-invasive, alternative treatment for disease

Mon, 18 Dec 2017 23:28:54 +0100

(Natural News) Artificial light has both its risks and benefits, but a new study shows that it may be the solution to minimally invasive, drug-free treatments. Researchers are currently developing new ways using infrared neuromodulation to treat cardiac arrhythmia (irregular heart beat), hypertension (high blood pressure), asthma, sleep apnea (suspension of breathing during sleep), diarrhea, and... (Source:

Zoll Medical, Myant ink next-gen LifeVest dev deal

Fri, 08 Dec 2017 18:59:12 +0100

Asahi Kasei Group company Zoll Medical said it inked an exclusive strategic multi-year deal with advanced manufacturing company Myant to develop technologies for future versions of Zoll’s LifeVest wearable defibrillator. The company’s LifeVest is designed to be worn by patients at risk of sudden cardiac death to monitor the heart continuously for abnormal heart arrhythmias and responds automatically, Zoll said. The system consists of an electrode belt and chest garment and a wrist-worn monitor. Read the whole story on our sister site, Medical Design & Outsourcing The post Zoll Medical, Myant ink next-gen LifeVest dev deal appeared first on MassDevice. (Source: Mass Device)

FDA approves Apple Watch's first medical device accessory

Fri, 01 Dec 2017 23:37:36 +0100

The FDA approved the KardiaBand, a mobile EKG add-on to the Apple Watch yesterday. Kardiaband is the first approved medical device to be used with the wearable tech, and can detect heart arrhythmias. (Source: the Mail online | Health)

Spinal Elements lifts former COO Blain to the corner office | Personnel Moves November 30, 2017

Thu, 30 Nov 2017 20:28:03 +0100

Spinal Elements, previously known as Amendia, said this week it is lifting co-founder and current prez & COO Jason Blain to the position of prez & CEO, effective immediately. Prior to coming on to co-found Spinal Elements, Blain served in various roles with medtech companies Smith & Nephew (NYSE:SNN), Alphatec (NSDQ:ATEC) and NuVasive Inc. (NSDQ:NUVA). Blain is replacing Chris Fair, who will stay on as a board member with the company. “I am excited by the opportunity to lead our talented team of employees and partners and create an even more vibrant and dynamic Spinal Elements in the years to come. I thank Chris Fair and the other members of our board of directors for their confidence. Going forward, Spinal Elements will continue to be focused on innovation and executi...

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.

Apple, Stanford launch Apple Heart Study to improve atrial fibrillation detection

Thu, 30 Nov 2017 14:02:29 +0100

The Apple Heart Study, an Apple Watch-based ResearchKit study using the heart rate sensor to look at potential arrhythmias, is launching today, the Cupertino tech giant told MobiHealthNews. (Source: mobihealthnews)

When Heart Disease Runs in the Family

Mon, 27 Nov 2017 21:27:04 +0100

Treatment TermsCardiomyopathy Overview Anne Goodes knew her heart beat faster than normal, but it wasn ’t until her local cardiologist detected a heart murmur that she discovered she was at risk for sudden cardiac death. At Duke, she learned the cause was hypertrophic cardiomyopathy, a common heart condition that can run in the family. Goodes soon discovered her children may need to take precaution s as well. Hero Image2017_anne_heart_596.jpg Preview Image Content Blocks Header Learning to Live with Hypertrophic Cardiomyopathy ContentHypertrophic cardiomyopathy affects the cells that make up the heart muscle, said Andrew Wang, MD, a cardiologist who directs the Duke Hypertrophic Cardiomyopathy Clinic in Durham, NC. It causes areas of the heart muscle wall to thicken, which makes ...

New AHA/ACC/HRS Guidance on Sudden Cardiac Death Prevention New AHA/ACC/HRS Guidance on Sudden Cardiac Death Prevention

Tue, 21 Nov 2017 21:02:24 +0100

Leading heart organizations provide up-to-date evidence-based recommendations on the treatment of ventricular arrhythmias and prevention of sudden cardiac death.Medscape Medical News (Source: Medscape Cardiology Headlines)

Can Fish Oil Help Reading?

Mon, 20 Nov 2017 00:12:50 +0100

Discussion Fats and fatty acids are essential for good human health. Saturated fats have hydrogen pairs linked to each carbon on the carbon backbone. They are solid or semi-solid at room temperature. Common examples are butter, lard, or hardened vegetable shortening. They are linked to higher cholesterol and triglycerides and only a small amount of them are recommended to be consumed in the diet. Unsaturated fats have one or more hydrogen atoms missing from the carbon backbone. They are liquid at room temperature. Monounsaturated fatty acids have one hydrogen pair that is missing from the carbon backbone. They are liquid at room temperature but start to become solid when placed into the refrigerator. Common examples are Canola oil, olive oil, peanut oil and avocados. They lower total ...

Shining a light on the nervous system to thwart disease

Tue, 14 Nov 2017 05:00:00 +0100

(Case Western Reserve University) Researchers from Case Western Reserve University School of Medicine, Vanderbilt University, and University of Pittsburgh have received a four-year, $9 million grant from the National Institutes of Health to develop enhanced infrared light technology (infrared neuromodulation) for potentially treating a variety of diseases, including cardiac arrhythmias, high and low blood pressure, asthma, sleep apnea and diarrhea, one of the leading killers of children worldwide. (Source: EurekAlert! - Medicine and Health)

MedWorm Message: If you are looking to buy something in the January Sales please visit for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.

URMC Cardiologist Receives High Honor from American Heart Association

Mon, 13 Nov 2017 22:44:31 +0100

University of Rochester Medical Center cardiologist Arthur J. Moss, M.D., whose research on cardiac arrhythmias has saved countless lives and changed the treatment of heart disease worldwide, was honored with the 2017 James B. Herrick Award at the American Heart Association ’s Scientific Sessions. (Source: University of Rochester Medical Center Press Releases)

Medical News Today: What is a sinus arrhythmia?

Sun, 12 Nov 2017 08:00:00 +0100

Sinus arrhythmias commonly cause irregular heartbeats in children. In this article, we look at the symptoms, types, and outlook for sinus arrhythmia. (Source: Health News from Medical News Today)

FDA warns black licorice can cause heart arrythmia

Tue, 31 Oct 2017 20:54:27 +0100

Beware of black licorice this Halloween if you're over 40, the FDA warns. Eating two ounces for two weeks or more can lower potassium levels, leading to heart arrhythmias and high blood pressure. (Source: the Mail online | Health)

FDA: Don't OD on Black Licorice This Halloween

Tue, 31 Oct 2017 14:14:05 +0100

For people 40 and older, eating 2 ounces of black licorice a day for at least two weeks could trigger an irregular heart rhythm (arrhythmia) and other troubles, the agency warned in advance of Halloween. (Source: WebMD Health)

Heart Groups Update Guidelines on Managing Ventricular Arrhythmias and Preventing Sudden Cardiac Death (FREE)

Tue, 31 Oct 2017 00:00:00 +0100

By Kelly Young Edited by David G. Fairchild, MD, MPH The American Heart Association, the American College of Cardiology, and the Heart Rhythm Society have released guidelines on treating patients who have ventricular arrhythmias or otherwise are at … (Source: Physician's First Watch current issue)

Black Licorice: Trick or Treat?

Mon, 30 Oct 2017 13:15:12 +0100

Black licorice is an old fashioned treat that can be harmful if you eat too much. If you're 40 or older, eating 2 ounces of black licorice a day for two weeks could cause an irregular heart rhythm (arrhythmia). (Source: FDA Consumer Health Information Updates)

How Genomic Research is Changing Heart Care

Fri, 27 Oct 2017 04:05:21 +0100

Genomic testing is most frequently associated with cancer testing, but this area of research is beginning to make an impact on cardiovascular care. A recent scientific statement by the American Heart Association shined a spotlight on how the expressed genome can potentially be used to diagnose diseases and predict who will develop diseases such as coronary artery disease (CAD), stroke, heart failure, and arrhythmias. According to the statement, scientists now have the ability to address disease at many levels that were inaccessible during the past century. This includes the genome, transcriptome, epigenome, proteome, metabolome, cells, tissues, and organs. The authors said each of the omics approaches is still a work in progress, and many of the initial findings have not yet been validated...

Study indicates home monitoring effectively detects potentially fatal fetal heart issues

Wed, 25 Oct 2017 04:00:00 +0100

(Children's Hospital Colorado) As reported in the Journal of Perinatology, researchers from Children's Hospital Colorado recently confirmed that it is feasible for at-risk pregnant women to use commercially available Doppler fetal heart rate monitors for home monitoring to detect heart arrhythmias in their developing fetuses. (Source: EurekAlert! - Medicine and Health)

FDA clears Acutus Medical ’ s AcQMap cardiac mapping tech

Tue, 24 Oct 2017 13:43:14 +0100

Acutus Medical said today that it won 510(k) clearance from the FDA for its AcQMap high-resolution imaging & mapping system and the 3D mapping catheter that goes by the same name. Carlsbad, Calif.-based Acutus said it plans to have the system on the U.S. market early next year. It’s designed to detect and display standard voltage-based and higher resolution charge-source maps, and is able to generate real-time, 3D images of the heart chamber using ultrasound. The system won CE Mark approval in the European Union in May 2016. “This clearance will allow electrophysiologists (EPs) in the U.S. access to a new technology that uses ultrasound to visualize cardiac anatomy and dipole density to map the pathway of every heartbeat. The system can also be used with existing commerci...

MedWorm Message: If you are looking to buy something in the January Sales please visit for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.

Acutus Medical(R) Receives FDA Clearance for Advanced Cardiac Mapping Technology for Complex Arrhythmias

Tue, 24 Oct 2017 13:06:44 +0100

FDA clearance of the AcQMap® High Resolution Imaging and Mapping System and AcQMap® 3D Imaging and Mapping Catheter is a major milestone for Acutus Medical Clearance allows the AcQMap System to be used with commercially available cardiac ablatio... Devices, Cardiology, FDA Acutus Medical, AcQMap, AcQMap 3D, electrophysiology (Source: HSMN NewsFeed)

Abbott Launches the First and Only Smartphone Compatible Insertable Cardiac Monitor in the U.S.

Mon, 23 Oct 2017 15:27:25 +0100


Abbott wins FDA nod for Confirm Rx smartphone-connected cardiac monitor

Mon, 23 Oct 2017 15:20:39 +0100

Abbott (NYSE:ABT) said today it won FDA clearance for its Confirm Rx insertable cardiac monitor, touting it as the 1st and only smartphone compatible ICM designed to help identify cardiac arrhythmias. The Confirm Rx system includes a sensor designed to be implanted just under the skin over the chest in a minimally-invasive outpatient procedure, the company said. The newly cleared device features incorporated Bluetooth wireless technology to allow patients to connect to the device on their smartphone devices through Abbott’s myMerlin mobile application. Data collected by the device is also transmitted to the patient’s physician on a schedule set by the practitioner, the company said. “Confirm Rx shows what we can do with cutting edge communication technology and the most...

Obesity Bigger Afib Risk Factor in Men than Women (CME/CE)

Tue, 17 Oct 2017 17:30:00 +0100

(MedPage Today) -- Men develop arrhythmia a decade earlier on average than women (Source: MedPage Today Cardiovascular)

Cardiologs raises $6m in Series A to support ECG Analysis Platform

Fri, 06 Oct 2017 14:00:23 +0100

Cardiologs Technologies said this week it raised $6.4 million in a Series A round of financing to support accelerated commercialization of its Cardiologs ECG Analysis Platform in the US and Europe. Funding in the round came from a syndicate of new investors including Idinvest, ISAI, Kurma Partners and Partech and was joined by the previously vested Bpifrance seed fund. The funds bring the total raised for the Paris-based company up to $10 million. “Cardiologs is the perfect example of applying state-of-the-art machine learning techniques to help professionals work much faster and more accurately. And in this case, it can save a lot of lives,” Idinvest managing partner Benoist Grossmann said in a press release. “Cardiologs has assembled a world-class team with a unique co...

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.

Nigeria: Experts Call for Basic Life Support Against Cardiac Arrest

Fri, 06 Oct 2017 10:50:16 +0100

[This Day] The Chief Executive Officer, Georgia Arrhythmia Consultants and Research Institute, Dr. Felix Sogade and Electrophysiologist, Cardiovascular Diseases and Internal Medicine, Dr. Joseph Poku, have called on Nigerians to learn basic life support skills as efforts to reduce the alarming incidence of sudden deaths among blacks, including Nigerians. (Source: AllAfrica News: Health and Medicine)

FDA clears Peerbridge Health ’ s Cor wireless ECG monitor

Thu, 05 Oct 2017 19:36:27 +0100

Health information technology company Peerbridge Health said this week it won FDA 510(k) clearance for its Peerbridge Cor wireless electrocardiogram monitor. The New York-based company claims the Cor has the smallest on-body footprint of any wearable monitor and provides multiple channels of ECG through water-resistant electrodes to enable continuous monitoring. Data from a clinical trial of the Cor device, carried out at New York’s Northwell Health System’s Lenox Hill Hospital, indicated that the wireless monitor was superior to a Holter Monitor, Peerbridge Health claims. “Early detection of atrial fibrillation and other arrhythmias is important to determine proper medical treatment, as these conditions are often silent and intermittent. They often become more difficult ...

Tom Petty Died of Cardiac Arrest. What Does That Mean?

Tue, 03 Oct 2017 14:07:45 +0100

This article originally appeared on (Source: Top Science and Health Stories)

Boston Scientific to acquire Apama Medical in deal worth up to $300m

Mon, 02 Oct 2017 21:14:37 +0100

Boston Scientific (NYSE:BSX) said today it inked a deal worth up to $300 million to acquire Apama Medical and its radiofrequency balloon catheter system designed to treat atrial fibrillation. The deal includes an initial $175 million in cash up-front from Marlborough, Mass.-based Boston Scientific and an additional $125 million in contingent payments between 2018 and 2020 based on clinical and regulatory milestones. Boston Scientific expects the acquisition to close the 4th quarter of 2017. Campbell, Calif.-based Apama’s novel RF balloon is a single-shot, multi-electrode device designed to combine the benefits of RF point-by-point and balloon-based ablation approaches, the company said, claiming the system delivers differentiated energy levels and shorter procedure times. The sys...

Getting to the heart of mapping arrhythmia-related excitations

Fri, 29 Sep 2017 04:00:00 +0100

(American Institute of Physics) Atrial fibrillation is the most prevalent form of cardiac arrhythmia, affecting up to 6 million people in the US alone. Common treatments for severe forms of the erratic beating phenomenon are controversial, and guided by detection methods that are not yet standardized or fully refined. But research from a group of cross-disciplinary scientists, published this week in the journal Chaos, offers a computational approach to understanding the important factors involved in measuring cardiac excitation waves. (Source: EurekAlert! - Medicine and Health)

MedWorm Message: If you are looking to buy something in the January Sales please visit for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.

CardioFocus lands CE Mark for next-gen atrial fibrillation balloon

Wed, 27 Sep 2017 17:07:09 +0100

CardioFocus said today that it won CE Mark approval for its HeartLight Excalibur balloon, designed for the treatment of atrial fibrillation. The Marlborough, Mass.-based company’s device combines the HeartLight endoscopic ablation system with features that optimize the speed and magnitude of target tissue contact during pulmonary vein isolation procedures, according to CardioFocus. The Excalibur balloon uses CardioFocus’ Dynamic Response technology, which is used to maximize the balloon’s engagement with a person’s pulmonary viens, while cutting the time needed to complete ablation procedures. “The new HeartLight Excalibur Balloon is designed to capitalize on the existing features of our HeartLight System, which offer an accurate, consistent and controlled tre...

Abbott Catches Up to Peers With MRI-Compatible ICD

Sat, 23 Sep 2017 04:38:19 +0100

Abbott Laboratories acquired St. Jude Medical earlier this year knowing that the company trailed behind its peers in the cardiac rhythm management (CRM) space by not having a MRI-compatible pacemaker or implantable cardioverter defibrillator (ICD) system. It seems Abbott has officially caught up in that category though, first with FDA approval of the Assurity MRI pacemaker and the Tendril MRI pacing lead during the first quarter, and now with FDA approval of MRI-conditional labeling for the Ellipse ICD system. Abbott said the recent approval covers one of its most widely-used ICD systems and associated high voltage leads. The approval is for the Ellipse ICD with the Tendril MRI pacing lead and Durata and Optisure high voltage leads. The new labeling allows patients with an Ellipse ICD pati...

Abbott wins MR-conditional label for Ellipse ICDs

Fri, 22 Sep 2017 12:54:06 +0100

Abbott (NYSE:ABT) said today that it won an MR-conditional label from the FDA for the Ellipse implantable cardioverter defibrillator it acquired along with St. Jude Medical early this year. The MR-conditional label applies to Ellipse and the Tendril MRI pacing lead and the Durata and Optisure high-voltage leads, the Chicago-area medical device giant said. “When you consider the number of patients each year who rely on the lifesaving treatment delivered by an ICD device, it is critical to continually innovate to provide new benefits to people battling complex arrhythmias and other cardiac conditions,” cardiac arrhythmias & heart failure CMO Dr. Mark Carlson said in prepared remarks. “By expanding our portfolio of MRI-compatible devices, we’re adding another benef...

Arrhythmia nurses to teach CPR technique on mountain top

Mon, 18 Sep 2017 00:40:00 +0100

Two specialist cardiac nurses are hoping to raise awareness of sudden cardiac death by teaching cardiopulmonary resuscitation (CPR) on the top of Snowdon, the highest mountain in Wales. (Source: Nursing Times)

Apple to partner with American Well, Stanford to launch heart arrhythmia trial with Apple Watch 3

Thu, 14 Sep 2017 17:18:18 +0100

Apple (NSDQ:AAPL) said this week it will partner with telemedicine company American Well and Stanford University to test the performance of its Series 3 Apple Watch to detect heart arrhythmias, according to a Fortune report. The tech giant announced the Apple Heart Study at its iPhone unveiling event earlier this week, saying that the company would seek to use the watch as a replacement for traditional heart sensors, according to the report. The new watch comes with an improved heart rate monitor which Apple claims will collect data including post-workout recovery heart rate and abnormal spikes in heart rate while resting, Fortune reports. Though the company didn’t reveal any new health-related innovations on its most recent iPhone 8 and iPhone X release announcement, CEO Tim Cook...

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.

Apple Watch Is Getting Way Better Heart-Rate Monitoring

Tue, 12 Sep 2017 18:37:26 +0100

Apple just announced upgrades to its Apple Watch, including changes to how the device tracks a user’s heart rate. The update comes with the Apple Watch’s watchOS 4, which comes out on Sept. 19. According to Apple COO Jeff Williams, the Apple Watch’s heart rate monitor is the most used in the world. Now the feature will be available to view on the Apple Watch’s face, making it easier to glance at quickly, especially when working out or running. The updated feature will also show your resting heart rate and your recovery heart rate—an indicator of fitness progress. The Apple Watch will remind you of your heart rate even when you’re not thinking of it by sending notifications if you want to see when you reach a certain heart rate while working out. The upda...

Sudden cardiac arrest while eating a hot dog: a rare presentation of Brugada syndrome in a child - Ozyilmaz I, Akyol B, Ergul Y.

Mon, 11 Sep 2017 08:38:42 +0100

Patients who are diagnosed with Brugada syndrome (BS) usually experience sudden cardiac arrest (SCA) and arrhythmia when they have a high fever, consume alcohol, and, more frequently, during their night sleep. In some rare cases, an SCA can be seen dependi... (Source: SafetyLit)

Is BioSig for Real This Time With Its Pure EP?

Thu, 07 Sep 2017 19:48:33 +0100

A couple years ago, BioSig Technologies, Inc. was poised to apply for FDA clearance to market its technology to improve treatment of atrial fibrillation and ventricular tachycardia. Then its scientific advisors advised the Minneapolis company to put more work into that technology, a hardware-software combination designed to present clearer signals during electrophysiology studies and catheter ablation. The technology, Pure EP, is designed to cut through the background noise of the lab and its equipment during cardiac recordings, enabling physicians to target and neutralize the areas of the heart that are causing atrial fibrillation (Afib), and ventricular tachycardia (VT), according to BioSig. More accurate targeting of the offending tissue may reduce the number of repeat catheter ablatio...

Cardiac Insight raises $5m, looks to raise $5m more

Thu, 07 Sep 2017 16:57:14 +0100

Cardiac Insight said today it raised $4.5 million in a new C-1 round of funding, looking to raise a total of $10 million in the round to support its Cardea Solo 7-day ECG sensor. Funds from the round will support sales, distribution and marketing of the company’s wearable Cardea Solo device, designed to provide both physicians and patients with cardiac data and help diagnose a variety of arrhythmias including atrial fibrillation. “Cardiac Insight has quickly caught the attention of the cardiology community for our game-changing products and revolutionary approach to cardiac care. Our new funding and leadership additions will continue to propel the company forward and highlight our distinct value proposition to cardiologists, healthcare institutions and patients,” CEO &am...

How a Bite of A Hot Dog Threatened -- and Saved -- a Boy's Life

Wed, 06 Sep 2017 13:00:00 +0100

It led to a medical crisis, and then discovery of hidden heart defect Source: HealthDay Related MedlinePlus Pages: Arrhythmia (Source: MedlinePlus Health News)

MedWorm Message: If you are looking to buy something in the January Sales please visit for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.

A 'virtual heart' to simulate arrhythmia

Wed, 06 Sep 2017 04:00:00 +0100

(Moscow Institute of Physics and Technology) A group of researchers from MIPT and Ghent University have proposed a mathematical model which is able to determine the factors responsible for the formation of different fibrosis patterns, which are believed to cause arrhythmia. To reproduce the formation of cardiac tissue, the researchers took a mathematical model -- one that is widely applied to study tissue growth -- and optimized it using the previously collected experimental data. (Source: EurekAlert! - Medicine and Health)

ESC: Frequent Smartphone Afib Monitoring Catches Arrhythmia (CME/CE)

Wed, 30 Aug 2017 00:35:00 +0100

(MedPage Today) -- But AliveCor device screening trial not powered for clinical outcomes (Source: MedPage Today Cardiovascular)

Abbott wins FDA nod for HeartMate 3 pump

Mon, 28 Aug 2017 13:00:10 +0100

Abbott (NYSE:ABT) said today that the FDA approved its HeartMate 3 implantable pump for heart failure patients awaiting a transplant. The approval is the latest for the HeartMate line of left ventricular assist devices first developed by Thoratec, which was later acquired by St. Jude Medical before a $25 billion merger brought it to Abbott earlier this year. Abbott said HeartMate 3 features full magnetic levitation for the pump’s impeller, aiming to cause less trauma to blood cells as they pass through the pump. Although it is smaller than its predecessor, Abbott claimed it has the industry’s largest “pump pathway.” The device won CE Mark approval in the European Union in October 2015. “Heart failure is a crippling and costly disease and the HeartMate 3 syst...

New Jersey family says 'marijuana killed' their son

Fri, 18 Aug 2017 17:22:16 +0100

Michael Ziobro, 22, died in his New Jersey home from a heart arrhythmia. His parents believe that marijuana is what caused the heart arrhythmia. They want people to be aware of the risks of smoking. (Source: the Mail online | Health)

Marijuana killed a man who died of a heart arrhythmia

Fri, 18 Aug 2017 16:46:19 +0100

Michael Ziobro, 22, died in his New Jersey home from a heart arrhythmia. His parents believe that marijuana is what caused the heart arrhythmia. They want people to be aware of the risks of smoking. (Source: the Mail online | Health)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.

Resting respiratory sinus arrhythmia in suicide attempters - Tsypes A, James KM, Woody ML, Feurer C, Kudinova AY, Gibb BE.

Mon, 14 Aug 2017 09:05:40 +0100

Although suicide attempts (SA) occur across a broad range of diagnoses as well as in the absence of a diagnosable disorder, most studies to date have focused on them within a single, specific disorder. Consistent with the NIMH RDoC initiative to identify b... (Source: SafetyLit)

Numerate receives NIH funding to discover new anti-arrhythmic treatments

Wed, 09 Aug 2017 23:00:00 +0100

The National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health (NIH) has awarded a small business innovation research (SBIR) Phase I grant to Numerate to boost a new drug programme for cardiac arrhythmias. (Source: Pharmaceutical Technology)

Evaluation of cardiac autonomic function using heart rate variability in children with acute carbon monoxide poisoning - Vural C, Dinleyici EC, Kosger P, Bolluk O, Kilic Z, Ucar B.

Mon, 07 Aug 2017 15:20:22 +0100

Introduction Carbon monoxide poisoning may cause myocardial toxicity and cardiac autonomic dysfunction, which may contribute to the development of life-threatening arrhythmias. We investigated the potential association between acute carbon monoxide exposur... (Source: SafetyLit)

Japan clears CardioFocus ’ HeartLight

Mon, 31 Jul 2017 20:14:55 +0100

CardioFocus said today it won approval from the Japanese Ministry of Health, Labour and Welfare for its HeartLight endoscopic ablation system with an indication for treating paroxysmal atrial fibrillation. The Marlborough, Mass.-based company’s HeartLight system is designed to allow electrophysiologists to control the delivery of laser energy through direct visual guidance to isolate pulmonary veins with a high procedural flexibility. The device includes a compliant balloon to accommodate diverse PV anatomies and has a short learning curve to allow for quick adoption of the tech, the company said. To support the newly cleared device in the region, CardioFocus said it inked a distribution partnership with Japan Lifeline, which will sell the HeartLight system through its electrophysiology...

Boston Scientific warns on fluke S-ICD death

Fri, 28 Jul 2017 12:01:53 +0100

Boston Scientific (NYSE:BSX) last month alerted physicians after learning of a fluke incident involving its S-ICD pacemaker, in which a patient died when the device’s memory was corrupted by radiation. In a June letter to physicians, Marlborough, Mass.-based Boston Scientific wrote of “a single, isolated S-ICD event that resulted in a device-related patient death in May of this year.” “Boston Scientific engineers have determined that this patient’s S-ICD repeatedly delivered an atypical amount of energy (similar to the arrhythmia induction function) because a specific memory location was corrupted by radiation within the environment. This repeated atypical energy delivery prevented S-ICD arrhythmia detection/treatment and ultimately contributed to the patient...

MedWorm Message: If you are looking to buy something in the January Sales please visit for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.

Could this algorithm be better at diagnosing arrhythmia than cardiologists?

Wed, 26 Jul 2017 15:12:28 +0100

[Image from Lars P. on Flickr]A new algorithm that can go through hours of heart data to detect arrhythmia performs better than trained cardiologists, according to new research from Stanford University. The algorithm gathers data from wearable monitors to find life-threatening irregular heartbeats and allows for data to be sorted through in remote areas where there is a scarcity of cardiologists. “One of the big deals about this work, in my opinion, is not just that we do abnormality detection but that we do it with high accuracy across a large number of different types of abnormalities,” said Awni Hannun, a graduate student and co-lead author of the paper, in a press release. “This is definitely something that you won’t find to this level of accuracy anywhere else.” Get the full...

Risk factors for myocardial dysfunction after traumatic brain injury: a one-year follow-up study - Lu K, Liang CL, Li PC, Liliang PC, Huang CY, Lee YC, Wang KW, Yang SN, Sun YT, Wang HK.

Sat, 22 Jul 2017 08:05:44 +0100

INTRODUCTION: Traumatic brain injury has been associated with an increased risk of myocardial dysfunction. Common abnormalities accompanying this pathology include electrocardiographic abnormalities, elevated creatine kinase levels, arrhythmias, and pathol... (Source: SafetyLit)

A sodium surprise

Thu, 20 Jul 2017 04:00:00 +0100

(Washington University in St. Louis) Irregular heartbeat -- or arrhythmia -- can have sudden and often fatal consequences. A biomedical engineering team at Washington University in St. Louis examining molecular behavior in cardiac tissue recently made a surprising discovery that could someday impact treatment of the life-threatening condition. (Source: EurekAlert! - Biology)

Working Too Much Might Tip Heart into Irregular Rhythm

Fri, 14 Jul 2017 13:00:00 +0100

Study shows a link between on-the-job hours and atrial fibrillation, but couldn't prove cause-and-effectSource: HealthDay Related MedlinePlus Pages: Arrhythmia, Atrial Fibrillation, Occupational Health (Source: MedlinePlus Health News)

Not all astrocytes in the brain are the same, study finds

Thu, 13 Jul 2017 16:53:00 +0100

From afar, the billions of stars in our galaxy look indistinguishable, just as the billions of star-shaped astrocytes in our brains appear the same as each other. But UCLA researchers have now revealed that astrocytes, a type of brain cell that supports and protects neurons, aren ’t all the same. While stars might be categorized by their size, age and heat, the supportive brain cells vary when it comes to shape, molecular machinery and functioning.The findings,published today in the journal  Neuron, should make it easier for researchers to study how astrocytes relate to disease, or to develop drugs that aim to target small subsets of astrocytes, said Baljit Khakh, a UCLA professor of physiology and neurobiology and the study’s senior author.“For 50 years, the textbooks have said th...

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.

Study: Post-AF ablation symptom reduction could be partly a placebo effect

Thu, 13 Jul 2017 15:35:37 +0100

Patient assessment of atrial fibrillation symptoms after being treated with catheter ablation may often not match physician assessments, according to a new study. While a number of patients reported relief of symptoms after the treatment, many of those individuals actually experienced persistent arrhythmia despite the procedure, according to the study, which was published late last month in the JACC: Clinical Electrophysiology journal. The study examined patients over 2 years, analyzing the success of AF ablation by evaluating patient reported and physician-assessed AF-related symptoms after the procedure. A total of 54 patients completed the 2-year follow up, according to the study. Patients in the study showed improvements across AF-specific symptom questionnaire AF6 and were evaluated b...

Arrhythmia, Obesity Predict Higher Radiation in Coronary CTA Arrhythmia, Obesity Predict Higher Radiation in Coronary CTA

Tue, 11 Jul 2017 22:02:57 +0100

It remains to be seen whether patient-specific factors"can be modified to reduce radiation to patients," but this single-center study"provides us with some intriguing data," says one expert.Medscape Medical News (Source: Medscape Medical News Headlines)

Cardiac Insight launches Cardea Solo wearable AF sensor

Tue, 11 Jul 2017 18:05:02 +0100

Cardiac Insight said today it launched its Cardea Solo electrocardiogram sensor designed for diagnosing atrial fibrillation following cardiac ablation. The Cardea Solo device is designed to provide both physicians and patients with cardiac data and help diagnose a variety of arrhythmias including atrial fibrillation, the Kirkland, Wash.-based company said. The Cardea Solo sensor is a lightweight, leadless, water resistant single-use disposable designed to record ECG data and patient symptoms.. The device can be worn under clothing for up to 7 days, the company said. “Cardiac Insight’s Cardea Solo is a game changer in the cardiac med-device market. Cardea Solo is an off-the-shelf product. It is not a service; so there is no lag time due to enrollment with a tech or third-party serv...

Using Zio data, Stanford team trains AI to best cardiologists at detecting 14 arrhythmias

Tue, 11 Jul 2017 11:40:26 +0100

A team of researchers from Stanford University, working with cardiac monitoring company iRhythm, have created an AI algorithm that, in a small proof-of-concept trial, outperformed board-certified cardiologists at identifying various types of arrhythmias from ECGs. (Source: mobihealthnews)

CathVision inks investment deal for electrophysiology system

Fri, 07 Jul 2017 19:38:05 +0100

Early-stage medical device company CathVision said today it inked a “multi-million venture investment” to support the development and marketing of its electrophysiology recording system designed for treating cardiac arrhythmia. The undisclosed investment came from Scandanavian-based VF Venture and Borean Innovation, Denmark-based CathVision said. “CathVision works in one of the fastest growing segments in medical technology. CathVision’s team has worked patiently and consistently with their product over a number of years, and we have followed the company for several years. I think CathVision represents an attractive investment target in a market with high activity,” VF Venture managing partner Tonni Bülow-Nielsen said in a prepared statement. “CathVisio...

MedWorm Message: If you are looking to buy something in the January Sales please visit for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.

CathVision Raises Venture Funding to Market New EP Recording System

Fri, 07 Jul 2017 12:57:41 +0100

Medical device company CathVision has signed a multi-million venture investment from Scandinavian-based investors VF Venture and Borean Innovation. The investment is directed at developing and market the company's superior electrophysiology (EP) recording ... Devices, Cardiology, Venture Capital CathVision, electrophysiology, arrhythmia, atrial fibrillation (Source: HSMN NewsFeed)

Creavo Medical raises $15m

Thu, 06 Jul 2017 20:56:53 +0100

Medical tech spin-out Creavo Medical Technologies said this week it raised $15.3 million (EU €13.4 million) in equity funding to help support its magnetocardiography diagnostic tech designed to measure, display and store electromagnetic fluctuations caused by heart activity. The round was led by IP Group and joined by existing investors the University of Leeds and newly invested Parkwalk Advisors and Puhua Capital, the UK-based company said. “We have supported Creavo from the very beginning and have been impressed with its substantial growth and ambition. I am particularly excited about this next chapter in Creavo’s evolution which will see its technology launched commercially for the benefit of patients and providers in the emergency room, a setting which continues to dominate t...

Cardiologs wins FDA 510(k) for ECG analysis platform

Thu, 06 Jul 2017 19:53:41 +0100

Cardiologs Technologies said today it won FDA 510(k) clearance for its Cardiologs ECG analysis platform designed to aid in the screening for atrial fibrillation and other arrhythmias. The platform is a cloud-based cardiac monitoring and analysis web service which uses artificial intelligence to analyze long-term ambulatory ECG monitoring recordings, the Paris-based company said. The system already has CE Mark approval in the European Union, the company added. “It is intuitive that screening for AFib and subsequent anticoagulant treatment should reduce the stroke burden, which is the basis of guideline recommendations to screen for AFib in persons over the age of 65. Unfortunately, current R-R interval based methods to detect AFib are characterized by an inferior Positive Predictive V...

60% of heart condition patients initially misdiagnosed

Thu, 06 Jul 2017 00:00:00 +0100

GPs urged to look out for signs of cardiac troubles Related items fromOnMedica Improvement in heart disease not uniform across UK Chronic heart failure – a review and update Modifying cardiovascular risks and lipid modification Death rate higher in women after discharge for heart arrhythmias New ‘treadmill test’ can predict mortality (Source: OnMedica Latest News)

Popular class of drugs reverse potentially harmful genetic changes from heart disease

Fri, 30 Jun 2017 04:00:00 +0100

(York University) Beta blockers are commonly used world-wide to treat a variety of cardiovascular conditions, such as arrhythmias and heart failure. Scientists have known for decades that the medications work by slowing the heart rate and reducing the force of contraction -- lessening the burden of work carried out by the heart. However, new research out of York University has now shown that these drugs also reverse a number of potentially detrimental genetic changes associated with heart disease. (Source: EurekAlert! - Medicine and Health)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.

Poorer patients more likely to leave hospital against doctors ’ advice

Mon, 26 Jun 2017 00:00:00 +0100

Poverty and gender are factors in unwise hospital discharge Related items fromOnMedica Acting without delay Hospitals sending home sick, vulnerable patients Poor discharge of elderly people costs NHS £820m Lack of post-discharge support puts vulnerable people at risk Death rate higher in women after discharge for heart arrhythmias (Source: OnMedica Latest News)

Adverse Drug Event Causality Analysis (ADECA): a process for evaluating evidence and assigning drugs to risk categories for sudden death - Woosley RL, Romero K, Heise CW, Gallo T, Tate J, Woosley RD, Ward S.

Sat, 24 Jun 2017 10:39:00 +0100

Growing evidence indicates that many drugs have the ability to cause a potentially lethal cardiac arrhythmia, torsades de pointes (TdP). This necessitates the development of a compilation of drugs that have this potential toxicity. Such a list is helpful i... (Source: SafetyLit)

Using CRM devices as forensic clues

Tue, 20 Jun 2017 13:45:52 +0100

Pacemakers and other cardiac rhythm management devices could help solve forensic cases by revealing a time and cause of death in cases where an autopsy is inadequate, according to a study presented today at EHRA Europace Cardiostim 2017. Lead author Dr. Philipp Lacour said in a statement that using CRM devices as clues could help satisfy an unmet need – nearly 30% of forensic cases remain unsolved because the autopsy does not clarify the cause or time of death. “The number of implanted cardiac devices with sophisticated diagnostic functions is increasing and we thought interrogating them might help to shed light on these unclear deaths,” Lacour said. “Currently, device interrogation is not routinely performed after autopsy.” Lacour teamed up with the Dept. of ...

BioTrace Medical touts real-world data from Tempo temporary lead

Mon, 19 Jun 2017 20:17:48 +0100

BioTrace Medical today released data from real-world experiences with its Tempo temporary pacing lead, touting no dislodgements or perforations and reliable pace capture during and after the procedure. The real-world experiences as well as 2 live cases were presented during the Transcatheter Valve Therapies 2017 in Chicago this week. In a presentation, Dr. Tamim Nazif of the NewYork-Presbyterian/Columbia University Medical Center released data from real-world experiences, including 3 cases from their Medical Center and several hundred other cases which reported no device-related adverse events, no perforations and dislodgements and an overall highly favorable operator feedback. “Our real-world experience with the Tempo Lead is consistent with the excellent results of the New Zealand ...

Study: Denervation May Reduce Recurrent Ventricular Arrhythmia (CME/CE)

Mon, 19 Jun 2017 18:35:03 +0100

(MedPage Today) -- Procedure should be considered early in disease course, researchers say (Source: MedPage Today State Required CME)

MedWorm Message: If you are looking to buy something in the January Sales please visit for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.

Tenth year of data on cardiac arrhythmia treatment launched at European congress

Sun, 18 Jun 2017 04:00:00 +0100

(European Society of Cardiology) The tenth year of data on cardiac arrhythmia treatment is being launched at EHRA EUROPACE - CARDIOSTIM 2017. (Source: EurekAlert! - Medicine and Health)

Medical News Today: Does the sound of airplanes raise blood pressure risk?

Wed, 14 Jun 2017 07:00:00 +0100

A new study investigates the effect of long-term exposure to aircraft noise on the risk of high blood pressure, cardiac arrhythmia, and stroke. (Source: Health News from Medical News Today)

Lessons from Fire Prevention: Why We Can Head Off Disease Without Sacrificing Cure

Sun, 11 Jun 2017 19:58:00 +0100

This insightful and data-filled evidence-based article from the Boston University School of Public Health  illustrates the work EMS can, and should, do to prevent disease where we cannot control curing it: Public health is concerned with creating a healthier world, preferably one where we prevent disease before it starts. This inevitably occasions grappling with our overwhelming investment in medicine and curative care, and arguing for a recalibration of our investment towards the social, economic, and cultural factors that promote health. We can educate people how to reduce their chances of suffering heart attacks, strokes and trauma. We can educate people of the significant risks of morbid obesity and the awful co-morbidity factors that accompany excessive weight: hypertension...

Athletes With ICDs: Reassurance in Long-Term Registry Athletes With ICDs: Reassurance in Long-Term Registry

Tue, 06 Jun 2017 20:30:30 +0100

Whether soccer stars, surfers, or equestrian elites, most athletes in the 4-year study competed safely without device failures to terminate arrhythmias as needed, despite inappropriate shocks in some.Heartwire from Medscape (Source: Medscape Medical News Headlines)

Sport Competition May Be Safe With ICD

Tue, 06 Jun 2017 18:35:02 +0100

(MedPage Today) -- No injuries or failure to terminate arrhythmia seen in registry (Source: MedPage Today Pediatrics)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.

Crawley two-year-old girl who could DIE at any moment

Tue, 06 Jun 2017 08:31:55 +0100

Verity Dewy, from Crawley, suffers from arrhythmia - an abnormal heart rhythm, which was sparked by the 4cm by 5cm growth. Her family are now trying to raise £100,000 for surgery to remove it in the US. (Source: the Mail online | Health)

Meet the two-year-old girl who could DIE at any moment

Tue, 06 Jun 2017 07:55:43 +0100

Verity Dewy, from Crawley, suffers from arrhythmia - an abnormal heart rhythm, which was sparked by the 4cm by 5cm growth. Her family are now trying to raise £100,000 for surgery to remove it in the US. (Source: the Mail online | Health)

Colorado medical device firm raises $2.1 million

Fri, 02 Jun 2017 13:12:22 +0100

CardioNXT, a Westminster medical device company, said it's raised $2.1 million in financing. The company said the latest money came from a group of investors led by James Bullock and William Hawkins, III. Piedmont Capital Partners and existing investors including Solas BioVentures also participated in the financing. The company said it's making technology targeting the understanding of c ardiac arrhythmias such as atrial fibrillation. "Atrial fibrillation is a huge problem globally. This technology… (Source: Health Care:Physician Practices headlines)

Is Epinephrine Safe for Older Patients with Anaphylaxis?

Thu, 01 Jun 2017 16:19:00 +0100

This study aimed to determine the clinical value, and potential cardiovascular harm, on elderly patients with anaphylaxis who received intramuscular (IM) and IV epinephrine. Over a five-year period, the researchers examined the ED record of anaphylactic patients over the age of 50 who were transported to two urban EDs. They compared the clinical outcome and cardiovascular complications between younger and older adults who received epinephrine for anaphylaxis. Of the 2,995 patients with allergy-related complaints, 492 were treated for anaphylaxis. Of them, 122 (24.8%) were older adults. Only 36.1% of the older patients received epinephrine as compared to 60.5% of the younger patients. Although only 0.9% of younger patients were more likely to get excessive doses ( > 0.5 mg IM or > 0.1...

Acute alcohol intoxication in an eight weeks old infant - Frenkel Rutenberg T, Benacun M.

Thu, 01 Jun 2017 16:05:51 +0100

INTRODUCTION: Alcohol intoxication in infants is a life-threatening condition which requires early diagnosis and treatment. It may lead to multi-system injury, including mental deterioration, respiratory depression, cardiac arrhythmia, metabolic disorders ... (Source: SafetyLit)

MedWorm Message: If you are looking to buy something in the January Sales please visit for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.

Quality of inpatient experience falling in some areas

Thu, 01 Jun 2017 00:00:00 +0100

CQC finds overall patient experience remains high Related items fromOnMedica Death rate higher in women after discharge for heart arrhythmias Emergency care struggling to guarantee safest care for all high-risk patients Who knows best when it comes to emergency hospital admissions? Hospital beds numbers down 20% in a decade Integrated health and social care workforces is the future (Source: OnMedica Latest News)

Chocolate May Reduce Risk Of Developing Common Heart Arrhythmia

Wed, 24 May 2017 10:00:00 +0100

While research has shown that consumption of primarily dark chocolate may have far reaching benefits for our heart health, new research now points to a secondary benefit for reducing the risk of developing a common heart arrhythmia known as atrial fibrillation. (Source: Healthcare News)

Holographic cardiac imaging among innovations showcased at arrhythmias congress

Thu, 18 May 2017 04:00:00 +0100

(European Society of Cardiology) Holographic cardiac imaging and other innovations will be showcased at the EHRA EUROPACE - CARDIOSTIM 2017 in Vienna, Austria. (Source: EurekAlert! - Medicine and Health)

10 innovative diagnostic tests to combat diseases

Wed, 17 May 2017 13:08:16 +0100

[Image from david__jones on Flickr]This is an exciting time for medical diagnostics, with recent innovations allowing for faster disease diagnosis than ever before. From cancer to diabetes to heart disease, here are 10 diagnostic tests that could change the game when it comes to catching diseases earlier. Next >> The post 10 innovative diagnostic tests to combat diseases appeared first on MassDevice. (Source: Mass Device)

Bathroom scales will inform about life threatening conditions

Tue, 16 May 2017 04:00:00 +0100

(Kaunas University of Technology) Weighing oneself has become one of the most common morning rituals. However, your weight is not the only message that can be delivered by your bathroom scales: the team of researchers at Kaunas University of Technology (KTU) Institute of Biomedical Engineering are developing the multifunctional scales, which can monitor your health and inform about potentially dangerous life conditions, such as arteriosclerosis or cardiac arrhythmia. (Source: EurekAlert! - Biology)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.